Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Microbiol Resour Announc ; 11(12): e0095322, 2022 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-36416544

RESUMO

We identified a double-stranded DNA (dsDNA) bacteriophage appearing to belong to Herelleviridae, genus Kayvirus. The bacteriophage, Biyabeda-mokiny 1, was isolated from breast milk using a clinical isolate of Staphylococcus aureus. The genome is 141,091 bp in length and encodes 230 putative coding sequences.

2.
Microbiol Resour Announc ; 11(12): e0095422, 2022 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-36409081

RESUMO

Two lytic double-stranded DNA (dsDNA) bacteriophages, belonging to the family Herelleviridae, were isolated from wastewater in Western Australia. Biyabeda-mokiny 2 appears to belong to the genus Kayvirus, and Koomba-kaat 1 to Silviavirus.

3.
Viruses ; 13(9)2021 09 11.
Artigo em Inglês | MEDLINE | ID: mdl-34578390

RESUMO

The emergence of multi-drug resistant (MDR) bacteria is recognised today as one of the greatest challenges to public health. As traditional antimicrobials are becoming ineffective and research into new antibiotics is diminishing, a number of alternative treatments for MDR bacteria have been receiving greater attention. Bacteriophage therapies are being revisited and present a promising opportunity to reduce the burden of bacterial infection in this post-antibiotic era. This review focuses on the current evidence supporting bacteriophage therapy against prevalent or emerging multi-drug resistant bacterial pathogens in respiratory medicine and the challenges ahead in preclinical data generation. Starting with efforts to improve delivery of bacteriophages to the lung surface, the current developments in animal models for relevant efficacy data on respiratory infections are discussed before finishing with a summary of findings from the select human trials performed to date.


Assuntos
Infecções Bacterianas/terapia , Farmacorresistência Bacteriana Múltipla , Terapia por Fagos/métodos , Infecções Respiratórias/terapia , Animais , Bacteriófagos/fisiologia , Ensaios Clínicos como Assunto , Modelos Animais de Doenças , Humanos , Pulmão/microbiologia , Camundongos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA